From: Hepatic steatosis in women with polycystic ovary syndrome
 | Non-overweight group N(%) | Overweight group N(%) | P |
---|---|---|---|
Central obesity | 16 (16.0%) | 93 (90.3%) | < 0.001 |
Increased blood pressure | 3 (8.8%) | 24 (50.0%) | < 0.001 |
Hypertriglyceridemia | 13 (12.5%) | 27 (26.2%) | 0.012 |
Hyperlipidemia | 36 (34.6%) | 50 (48.5%) | 0.042 |
Abnormal blood glucose | 18 (17.1%) | 36 (35.6%) | 0.003 |
HOMA-IR ≥ 3.54 | 10 (9.9%) | 59 (50.0%) | < 0.001 |
Metabolic syndrome | 1 (0.9%) | 35 (34%) | < 0.001 |
Abnormal liver enzymes | 8 (7.5%) | 20 (19.4%) | 0.012 |
ALT ≥ 18.2 | 32 (30.2%) | 61 (59.2%) | < 0.001 |
FAI > 8 | 25 (26.6%) | 50 (57.5%) | < 0.001 |
Hirsutism | 34 (32.4%) | 33 (32.7%) | 0.964 |
Acne | 50 (47.6%) | 45 (44.1%) | 0.613 |
PCOM | 84 (88.4%) | 82 (92.1%) | 0.397 |